About Alessa Therapeutics
Alessa Therapeutics is a private company based in San Carlos, California. It has reported $31,641,454 raised in three offerings on Form D since March 2019. Its chief executive is Cam Gallagher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 18, 2025 | May 1, 2025 | $25,376,457of $31.6M target | 14 | $1.8M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 19, 2019 | Jan 2, 2020 | $3,264,998of $3.4M target | 2 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Mar 11, 2019 | Mar 26, 2019 | $2,999,999of $3.4M target | 2 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $31,641,454 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alessa Therapeutics's Form D filed May 1, 2025.
ZC
Zachary Collins
Executive officer
CG
Cam Gallagher
Chief Executive Officer and director
ST
Steve Tregay
Director
DC
Douglas Crawford
Director
AM
Annie Mitsak
Director
RL
Richard Lim
Director
PM
Pamela Munster
Director
Earlier filings also listed Peter Parker (director, last listed Jan 2020) and John Maroney (president and director, last listed Jan 2020).